In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
207 News Items found
Woman in field with dog dressed as tiger
A Surgical Milestone To Protect Fertility in Young People With Cancer

MSK surgeons do an innovative procedure called a uterine transposition — the first performed in the U.S. — to preserve a woman’s fertility during cancer treatment.
MSK bile duct cancer patient Berta Pesantez
How MSK Is Making Cancer Clinical Trials in NYC Easier To Access

For many patients, time is of the essence. At MSK, patients have access to potentially lifesaving therapies long before they are available at community hospitals. Learn how MSK’s Cancer Health Equity Research Program (CHERP) partners with a network of public hospitals in New York City to recruit underserved patients for clinical trials at MSK and give them access to world-class care.
Dr. Debyani Chakravarty
Why New Precision Oncology Cancer Treatments Benefit Patients of Some Ancestries More Than Others

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.
Memorial Sloan Kettering Among the Top “Best Hospitals” for Cancer Care and Ranked First in Gynecology by U.S News & World Report

Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology.
MSK patient Dana Vergara smiles as she holds her baby Hudson.
Baby Hudson Makes History

Learn about Dana and the uterine transposition surgery at MSK in NYC, that enabled her to give birth to a baby named Hudson, who made history.
Bob Li, MD, PhD, MPH
First-Ever KRAS Inhibitor Gets Accelerated Approval for Non-Small Cell Lung Cancer

Memorial Sloan Kettering’s Bob Li served as principal investigator of the CodeBreaK 100 trial, the largest clinical trial conducted to date exclusively for patients with the KRAS G12C mutation.
John Mendelsohn
Feature
Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer

The scientific world lost one of its greats this week. Here, we reflect on his influence.
A close up of a microscope with two people wearing white coats in the background
ESMO 2025: MSK Presents New Research, Including Latest on Lung and Pancreatic Cancer Treatments

MSK highlights from the recent European Society for Medical Oncology (ESMO) Congress include promising findings on new lung, pancreatic, and colorectal cancer treatments and new insights for how molecular testing can guide personalized medicine.
MSK urologic surgeon Timothy Donahue
In the Clinic
New Imaging Technique Could Reduce Side Effects of Prostate Cancer Surgery

Learn how a new imaging approach lights up nerves so they can be avoided during prostate cancer surgery.
MSK-IMPACT
The National Cancer Act @ 50: Reflecting on Half a Century of Cancer Research

Fifty years ago, the signing of the National Cancer Act ushered in a new era of cancer research and care.